Sequencing is the process of reading the exact order of chemical building blocks in a DNA molecule. Every cell in your body contains DNA made up of four bases, commonly referred to by their initials: A, T, C, and G. The specific order of these letters encodes the biological instructions your cells use to develop, function, and reproduce. Sequencing is how scientists and doctors decode that instruction manual.
How Sequencing Works
Think of DNA as an enormously long string of text written in a four-letter alphabet. A single human genome contains roughly 3 billion of these letters. Sequencing technology reads those letters in order, then software stitches the short reads together into a complete picture, much like assembling a jigsaw puzzle by matching overlapping edges.
The raw output is essentially a massive text file of A’s, T’s, C’s, and G’s. From there, computer programs align those reads against a reference genome (a well-established “template” of human DNA), flag any differences, and determine what those differences mean biologically. Some differences are harmless. Others sit inside genes that affect how proteins are built or how your body processes a medication, and those are the ones that matter clinically.
Older Methods vs. Modern Platforms
The first generation of sequencing technology, developed in the 1970s, read one small stretch of DNA at a time. Using that approach, completing the first draft of the human genome took over a decade of work across dozens of laboratories worldwide. It was accurate but painstakingly slow.
Modern platforms, collectively called next-generation sequencing, read millions of DNA fragments simultaneously. An entire human genome can now be sequenced within a single day. These newer machines are also more sensitive. They can pick up genetic changes present in only a small percentage of cells, something the older method frequently missed. And because they capture so many types of genetic variation in one run, they’ve replaced what used to require multiple separate tests.
What Sequencing Costs Today
The price of sequencing a human genome has dropped dramatically. Clinical-grade genome sequencing for a single patient currently runs in the range of a few thousand dollars (Canadian data puts it around C$3,645 to C$5,344, depending on how much analysis is needed). That cost fell by 61% over just four years in one recent study. A significant chunk of the expense now comes not from the sequencing itself but from the computing power and expert analysis required to interpret the results, which can account for anywhere from 21% to 58% of the total bill.
Sequencing in Medical Diagnosis
One of the most impactful uses of sequencing is diagnosing rare genetic diseases, especially in children. Doctors can sequence either the entire genome or just the protein-coding portions (called the exome). The exome covers only about 1% to 2% of total DNA but contains roughly 95% of the regions known to cause disease. Exome sequencing provides a diagnosis in 25% to 35% of cases where standard testing has come up empty.
Speed matters in hospital settings. When a critically ill newborn needs answers, rapid sequencing protocols aim to deliver results as fast as possible. In practice, the average turnaround time is about 18 days from sample collection to diagnosis, though the fastest cases have come back in as few as 3 to 5 days. About 4 of those days, on average, are simply shipping and processing time before the lab even begins.
Matching Medications to Your Genes
Sequencing also helps doctors choose the right drug and dose for individual patients. Your genes influence how quickly you break down certain medications, which means the same pill can work perfectly in one person and cause a dangerous reaction in another.
A clear example involves blood thinners prescribed after a heart stent. One common antiplatelet drug requires a specific liver enzyme to become active. People who carry a genetic variant that impairs that enzyme don’t activate the drug efficiently, raising their risk of a blood clot in the stent. A simple genetic test before prescribing can flag these patients so doctors can switch to an alternative that doesn’t depend on the same pathway.
Similar testing is used for the gout medication allopurinol (carriers of a specific gene variant face serious hypersensitivity reactions and should take a different drug), certain chemotherapy agents (where a gene variant can cause life-threatening toxicity at standard doses), epilepsy medications like carbamazepine, and the HIV drug abacavir. In each case, sequencing a small panel of genes before prescribing can prevent a harmful reaction or a drug that simply won’t work.
Cancer Detection Through Blood Draws
Tumors constantly shed tiny fragments of their DNA into the bloodstream. Sequencing can detect these fragments, known as circulating tumor DNA, in a standard blood sample. Because tumor DNA carries specific mutations and chemical tags that normal DNA doesn’t, sequencing can distinguish cancer-derived fragments from the background noise of healthy cell fragments.
One key technique exploits the fact that cancer cells often have unusual chemical modifications on their DNA. By treating a blood sample with a chemical that converts unmodified DNA bases but leaves the modified ones intact, sequencing can reveal the methylation pattern at single-letter resolution. This allows doctors to detect cancer signals without a traditional tissue biopsy, opening the door to earlier detection and ongoing monitoring through a simple blood draw.
Tracking Wildlife and Ecosystems
Sequencing isn’t limited to human medicine. Every organism leaves traces of DNA in its environment: skin cells in water, root fragments in soil, saliva on a leaf. Scientists can collect a water or soil sample, extract all the DNA in it, and sequence everything at once to identify which species are present. This approach has become a core tool for ecologists and environmental managers since the late 2000s.
The technique is especially valuable for detecting species that are hard to observe directly, like rare aquatic animals or soil-dwelling organisms. It also works for identifying plant pathogens when a crop shows disease symptoms but no organism is visible under a microscope. The method was first demonstrated in lake sediments back in 1987, but affordable sequencing technology has transformed it from a niche experiment into a routine monitoring tool used across aquatic and, increasingly, terrestrial ecosystems.